Search results
-
Blog
Case Study: How to Evaluate Human Abuse Potential (HAP) for CNS Drugs
Altasciences supported a client with HAP studies for the development of a novel analgesic, mirogabalin, currently marked in Japan, Korea, Taiwan, and China.
-
Blog
Internships at Altasciences: Q&A With Our Summer Interns
Altasciences’ interns reflect on their experience and what they’ve learned.
-
Scientific Publication
Strategies to Improve Assay Sensitivity to Quantify Therapeutic Oligonucleotides
-
Blog
Five Promising Treatment Areas in Early-Phase Drug Development in 2024
Explore emerging areas of drugs from psychedelics and gene therapy, oligonucleotides to GLP-1RA for metabolic disorders.